Renal Biomarkers Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032

1
Global Renal Biomarkers Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Renal Biomarkers Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global renal biomarkers
  market size reached US 1.3 Billion in 2023.
• Renal biomarkers refer to cells, proteins,
  lipids, microRNAs, genes, metabolites, or
  proteomic patterns that determine the glomerular
  filtration rate (GFR) of the kidney. They are
  used to identify the patients at risk of
  developing kidney diseases by measuring their
  blood or urine levels.
• They also assist in computing drug dosage and
  evaluating pathogenic processes or
  pharmacological responses to therapeutic
  interventions. Owing to these benefits, renal
  biomarkers find extensive applications across
  laboratories and hospitals across the globe.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/renal-biomarkers-market
  /requestsample

4
Report Description

• Global Renal Biomarkers Market Trends
• The market is primarily driven by the growing
  prevalence of chronic kidney diseases (CKD) among
  individuals across the globe. In addition, the
  increasing utilization of novel single biomarkers
  and process-specific biomarker panels to evaluate
  response to the treatment of glomerulopathies,
  acute kidney injury (AKI), and autosomal dominant
  polycystic kidney disease (ADPKD) is positively
  influencing the market growth. Besides this,
  renal biomarkers are widely utilized in
  laboratories to assess the safety and efficiency
  of new drugs in preclinical and clinical trials.
• This, coupled with the development of genomics,
  epigenetics, transcriptomics, proteomics, and
  metabolomics, is creating a positive market
  outlook across the globe. Furthermore, the
  increasing government investments in developing
  healthcare infrastructure, the rising geriatric
  population, and extensive research and
  development (RD) activities and trials for CKD
  are some of the other factors propelling the
  market growth.
• Looking forward, IMARC Group expects the market
  value to reach US 2.5 Billion by 2032,
  exhibiting a CAGR of 6.9 during the forecast
  period (2024-2032).
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/renal-biomarkers-market
  

5
Report Segmentation

• Breakup by Biomarker Type
• Functional Biomarker
• Serum Creatinine
• Serum Cystatin C
• Urine Albumin
• Up-regulated Protein
• Neutrophil Gelatinase-Associated Lipocalin (NGAL)
• Kidney Injury Molecule-1
• INTERLEUKIN-18
• Others
•  
• Breakup by Diagnostic Technique
• Enzyme-linked Immunosorbent Assay (ELISA)
• Particle-enhanced Turbidimetric Immunoassay
  (PETIA)
• Colorimetric Assay

6
Report Segmentation

• Chemiluminescent Enzyme Immunoassay (CLIA)
• Liquid Chromatography Mass Spectrometry (LC-MS)
• Breakup by End User
• Hospital
• Diagnostic Laboratory
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Laboratories
• Beckman Coulter Inc. (Danaher Corporation)
• bioMérieux SA
• BioPorto A/S
• Bio-Rad Laboratories Inc.
• Enzo Biochem Inc.
• F. Hoffmann-La Roche AG
• PerkinElmer Inc.
• Randox Laboratories Ltd.
• Siemens AG
• Thermo Fisher Scientific Inc.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Renal Biomarkers
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Biomarker Type
• 6.1 Functional Biomarker
• 6.1.1 Market Trends
• 6.1.2 Key Segments
• 6.1.2.1 Serum Creatinine
• 6.1.2.2 Serum Cystatin C
• 6.1.2.3 Urine Albumin
• 6.1.3 Market Forecast
• 6.2 Up-regulated Protein
• 6.2.1 Market Trends
• 6.2.2 Key Segments       

10
Table of Contents

• 6.2.2.1 Neutrophil Gelatinase-Associate
  d Lipocalin (NGAL)
• 6.2.2.2 Kidney Injury Molecule-1
• 6.2.2.3 INTERLEUKIN-18
• 6.2.3 Market Forecast
• 6.3 Others
• 6.3.1 Market Trends
• 6.3.2 Market Forecast
• 7 Market Breakup by Diagnostic Technique
• 7.1 Enzyme-linked Immunosorbent Assay
  (ELISA)
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Particle-enhanced Turbidimetric
  Immunoassay (PETIA)
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Colorimetric Assay
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Chemiluminescent Immunoassay (CLIA)
• 7.4.1 Market Trends

11
Partial List of Clients
12
Partial List of Clients
13
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us